The continuing medical education community is under attack by the government and the media for allowing pharmaceutical industry marketing messages to creep into educational activities. But how often do physician participants perceive commercial bias? And when they do observe it, where do they place the blame? When weighing an activity's objectivity, how important are faculty disclosures of their financial relationships with industry? For the first time, Medical Meetings asked those
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments